Karvy Stock Broking has upgraded Aurobindo Pharma to `Buy` from `Hold` with a price target of Rs 138 as against the current market price of Rs 118 with upside potential of 17% in its report dated Feb. 15, 2012.
Karvy upgrades Aurobindo Pharma to 'BUY'